DocGo (NASDAQ:DCGO – Get Free Report) will be issuing its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.04 per share for the quarter. DocGo has set its FY 2024 guidance at EPS.Parties that wish to register for the company’s conference call can do so using this link.
DocGo (NASDAQ:DCGO – Get Free Report) last announced its earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). DocGo had a net margin of 3.97% and a return on equity of 8.90%. The firm had revenue of $164.95 million during the quarter, compared to analyst estimates of $166.61 million. On average, analysts expect DocGo to post $0 EPS for the current fiscal year and $0 EPS for the next fiscal year.
DocGo Price Performance
Shares of NASDAQ:DCGO opened at $3.38 on Tuesday. DocGo has a 1 year low of $2.75 and a 1 year high of $6.90. The firm has a market capitalization of $345.84 million, a P/E ratio of 12.07, a P/E/G ratio of 3.10 and a beta of 0.89. The business’s 50-day moving average is $3.45 and its 200 day moving average is $3.32.
Analyst Ratings Changes
Read Our Latest Analysis on DCGO
About DocGo
DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.
Further Reading
- Five stocks we like better than DocGo
- Business Services Stocks Investing
- Mobileye’s Recovery Steadily Gains Traction with Novel AI
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Options Traders Bet Big on These 3 Tech Stocks
- What Does Downgrade Mean in Investing?
- Rise of AI Agents vs. RPA Bots: 3 Stocks to Watch Now
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.